This program is sponsored by Santen.
TobraDex ST: A Reliable Treatment for Blepharitis and Inflammation With Increased Ocular Bio-Availability
This program is sponsored by Santen.
This program is sponsored by Santen.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Improved grading scales for oncology drugs causing ocular adverse events
5
.png "Optometry Times"){kind=logo}
